featured
Risk for Low Visual Acuity in Neovascular AMD After 1 or 2 Years of Anti-VEGF Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Retina (Philadelphia, Pa.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk for Low Visual Acuity After 1 and 2 Years of Treatment With Ranibizumab or Bevacizumab for Patients With Neovascular Age-Related Macular Degeneration
Retina (Philadelphia, Pa.) 2017 Jan 30;[EPub Ahead of Print], I Westborg, S Albrecht, A RossoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.